Firebrick Pharma Limited (AU:FRE) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Firebrick Pharma Limited has announced the cessation of Richard Treagus as a director of the company effective September 30, 2024. Additionally, a disclosure was made regarding the interest of 100,000 options at $0.42 expiring on November 23, 2026, held beneficially by Ms. Karen E Treagus under the Treagus Family Account. The notice underscores the importance of transparency in the management changes and interests within the company.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.